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Abstract
The literature comparing the performance of algorithms for assigning cause of death using ver-
bal autopsy data is fractious and does not reach a consensus on which algorithms perform best,
or even how to do the comparison. This manuscript explains the challenges and suggests a way
forward. A universal challenge is the lack of standard training and testing data. This limits
meaningful comparisons between algorithms, and further, limits the ability of any algorithm to
classify verbal autopsy deaths by cause in a way that is widely generalizable across regions and
through time. Verbal autopsy algorithms utilize a variety of information to describe the relation-
ship between verbal autopsy symptoms and causes of death - called symptom-cause information
(SCI). A crowd sourced, public archive of SCI managed by the World Health Organization
(WHO) is suggested as a way to address the lack of SCI for developing, testing, and comparing
verbal autopsy coding algorithms, and additionally, as a way to ensure that algorithm-assigned
causes of death are as accurate and comparable across regions and through time as possible.
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1 Essential Components of VA Algorithms
VA cause-assignment algorithms rely on three components: (i) VA data, (ii) symptom-cause
information (SCI), and (iii) a logical algorithm that combines the two to identify
cause-specific mortality fractions (CSMF)s and/or assign a likely cause of death to
each death. The SCI describes how VA symptoms are related to each cause – either elicited
directly physicians or in the form of a dataset of VAs and causes assigned using a different mecha-
nism, e.g. medical records review (more on this below). Additionally, algorithms produce different
outputs. All create CSMFs, but some do not assign causes to individual deaths. Among those
that do, some assign one cause to each death while others assign a propensity or a probability to
every cause for each death. Those that assign a number to each cause report a summary of those
numbers for each death, often the three causes with the largest number.
The three components listed above – data, SCI, and logic – each affect the performance of VA
algorithms. It is possible to compare the effects of each by holding the other two constant. Of
obvious interest are the effects of the algorithm logic and the SCI. In a comparison of this type
the VA data must be held constant, and the algorithm logic and SCI varied independently – i.e.
one varied while holding the other constant. Differences observed in causes assigned to individual
deaths and in CSMFs can then be attributed to either the algorithm logic or the SCI. Most published
comparisons conflate the effects of logic and SCI by varying both together in unsystematic ways.
When that happens, differences in the causes assigned and CSMFs are due to differences in both the
logic and SCI, and it is not possible to determine how much each component affects the differences.
In order to isolate the effect of algorithm logic, both the VA data and the SCI must be held constant
and only the algorithm logic allowed to vary.
Finally, the software that implements an algorithm often contains additional logic to either prepro-
cess the data (e.g. so that impossible symptom combinations are not included) or to postprocess the
results (e.g. to ensure that ‘impossible’ causes are not reported, such as pregnancy-related deaths
for males). These software features are typically not reported in the publication that describes
the method, but they can have important consequences for the real-world application of the algo-
rithm. Because of this, and the fact that transparency encourages both trust and innovation, it is
important to have access to the source code for the software that implements an algorithm.
2 Factors to Consider when Comparing the Performance of VA
Algorithms
Beyond the design of the comparison, additional factors affect the how the comparisons are done
and how to interpret them.
Algorithmic comparisons require VA data and SCI, and both are related to real deaths – VA
data are obtained from real deaths and SCI are often derived from real deaths that have causes
assigned through a mechanism other than VA. Because VA is most useful and most often applied
to community deaths that occur outside of health facilities, it is important to know what types
of deaths are included in the VA data and SCI, either ‘community deaths’ or ‘hospital deaths’.
Clearly, hospital deaths are less relevant to VA applications that target deaths occurring in the
community.
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The algorithm logic is of obvious importance, as is the SCI (see above and below). Beyond those,
the structure of the test is important: does it use real data or is it a simulation study, what are
the details of the metrics used to characterize and compare the performance of the algorithms, and
how are causes and symptoms included in the test – at their ‘natural’ frequencies or resampled to
over/under-represent certain symptoms or causes.
Perhaps most important is whether the test deaths are part of the training data or completely
different. A common test design involves obtaining a large collection of deaths with both VA data
and causes assigned through another mechanism. All of the testing and comparisons are done
using these ‘gold standard’ deaths. A sample of these deaths is used to generate the SCI for the
algorithms, and then the algorithms are run on the remaining deaths, and the results compared.
This setup holds both the VA data and SCI constant and conducts tests on deaths that are on
average indistinguishable from those used to generate the SCI. Any differences observed in this
setup are created by the algorithms and nothing else. This characterizes how well each algorithm
performs if an algorithm is applied to VA data that were not used to build the logic of the algorithm,
and the results can be used to fairly compare algorithms without worrying about the effects of SCI.
However, this test does not indicate how well the algorithms perform when using different SCI
or when applied to different deaths. This is critical because most tests done using a framework
like this are conducted on gold standard hospital deaths. In that case, the results say little about
how the algorithms perform on community deaths. At this time, there are no good gold standard
datasets for community deaths, so it is not possible to do the test we really want.
Some published comparisons do compare the performance of algorithms on community deaths or
the performance of algorithms to physician coding using community deaths. In these cases there
is no additional reference cause of death to which either algorithms or physician codes can be
compared, so the results are difficult to interpret. If the physician codes are viewed as a reference,
then the performance of algorithms can be assessed relative to physicians.
3 Symptom-Cause Information (SCI)
SCI describes how VA symptoms are related to each cause. SCI are different from ‘training data’
because they can include both labeled data (traditional training data) and other forms of knowledge
that inform the relationship between symptoms and causes. There are effectively two commonly-
used collections of SCI: (i) the InterVA SCI (Byass et al., 2012), and (ii) the Population
Health Metrics Research Consortium (PHMRC) gold standard dataset (Murray et al.,
2011).
The InterVA SCI was developed in an iterative way in several population surveillance research sites
in South Africa, Ethiopia and Vietnam. Consequently the InterVA SCI broadly relate to those
specific populations and cannot be readily updated or adapted. The PHMRC SCI are derived from
the PHMRC gold standard dataset of deaths with VA and medically certified causes.
The PHMRC dataset contains deaths that occurred in hospitals in six populations (Andhra Pradesh,
India; Bohol, Philippines; Dar es Salaam, Tanzania; Mexico City, Mexico; Pemba Island, Tanzania;
and Uttar Pradesh, India) in the years leading up to 2011. Consequently the PHMRC SCI describes
the relationships between VA symptoms and causes of death in hospitals in those six specific
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populations during the late 2000s. These relationships have likely shifted with time and are likely
of limited applicability in other geographic locations.
SCI relate VA symptoms to causes of death, and consequently, a specific SCI comes with a defined
symptom list and a defined cause list. The InterVA SCI symptom and cause lists correspond to the
WHO 2012 and WHO 2016 standard VA tools (World Health Organization, 2012, 2017), while the
PHMRC SCI symptom and cause lists correspond to those defined by the original PHMRC study
(Murray et al., 2011). Some algorithms use subsets of the symptom and causes lists for a given
SCI.
4 VA Algorithms
There are six computational algorithms that have been seriously proposed and/or used widely.
Physicians can also be thought of as an algorithm, and there are additional algorithms that have
been proposed but not considered seriously for real-world use, e.g. several earlier propositions by
the Institute for Health Metrics and Evaluation (IHME), e.g. ‘Random Forest’ and ‘Simplified
Symptom Pattern’.
The InterVA algorithm (e.g. Byass et al., 2012; Fottrell et al., 2007; Oti and Kyobutungi, 2010;
Fantahun et al., 2006; Fottrell et al., 2011) was developed and refined by Peter Byass and his col-
leagues over many years and is currently in version 5, to be released soon. InterVA uses a reduced
version of Bayes rule and SCI in the form of conditional probabilities of experiencing a symptom
given a specific cause of death: Pr(s|c). The conditional probabilities are elicited from physicians,
and in the latest version of InterVA (InterVA-5), the PHMRC gold standard dataset also informs
some of the conditional probabilities. InterVA identifies a propensity for each cause of death for
each death and derives CSMFs by adding up those propensities across all deaths in a VA dataset.
There is open-source software available for InterVA4.
• Open source windows software: http://interva.net
• Open-source R package: https://cran.r-project.org/package=InterVA4
The Tariff algorithm (James et al., 2011) was developed by IHME and has been refined as the
SmartVA algorithm (Serina et al., 2015b,a) that requires fewer symptoms than Tariff and can
classify some causes better than Tariff. The Tariff family of algorithms use an additive tariff score
to rank causes for each death. SCI for the Tariff algorithms are individual tariffs that correspond to
the strength of association between particular symptoms and causes in the PHMRC gold standard
dataset. The SmartVA-Analyze computer software adds some ‘expert opinion’ to the SCI derived
from the PHMRC gold standard dataset. The Tariff methods identify the single cause with the
highest rank for each death in a VA dataset and add those up to derive CSMFs. There is free
proprietary software for SmartVA-Analyze available from IHME and an open-source R package to
implement Tariff.
• SmartVA-Analyze: http://www.healthdata.org/verbal-autopsy/tools
• Open-source Tariff R package: https://cran.r-project.org/package=Tariff
The InSilicoVA algorithm (McCormick et al., 2016a,b) was developed recently by our group of
demographers and statisticians at the University of Washington and The Ohio State University.
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InSilicoVA is a statistical algorithm based on Bayes rule that jointly identifies the most likely
cause assignments for each death and the corresponding CSMFs for all deaths in a VA dataset.
InSilicoVA can use a variety of SCI including both the InterVA and PHMRC SCI and others if they
are available. InSilicoVA assesses uncertainty (e.g. provides credible intervals) in both individual
cause assignments and CSMFs and is the only algorithm to do this. There is an R package for
InSilicoVA and reproducibility code available from the authors.
• Open-source InSilicoVA R package: https://cran.r-project.org/package=InSilicoVA
The NBC (naive Bayes classifier) algorithm (Miasnikof et al., 2015) was developed by a group of
statisticians and epidemiologists at the University of Toronto. NBC is a direct application of Bayes
rule as a standard naive Bayes classifier. As presented by its developers, NBC uses custom SCI
derived by the Toronto group related to deaths in India. There is an R package available that
accepts training data and VA data so that the method can use a variety of SCI.
• Open-source NBC R package: https://cran.r-project.org/package=nbc4va
The King-Lu algorithm (King et al., 2008, 2010) was developed by King and Lu and uses Bayes
rule to estimate only the the CSMFs using constrained optimization. The algorithm itself does not
perform individual classification, but the authors describe a possible two-stage approach. The King-
Lu method also relies on the SCI from training data. Uniquely, the King-Lu method considers the
SCI described by groups of symptoms, instead of each symptom alone. Therefore it must use high
quality gold standard deaths, preferably from the same population as the VA deaths, or otherwise
researchers need to know which small groups of symptoms to use. This makes it impossible to
use King-Lu in a situation without gold standard deaths. There is an R package for the King-Lu
method.
• Open-source King-Lu R package: https://gking.harvard.edu/va
There is an open-source R package called ‘openVA’ that runs all of the open-source R packages listed
above, except King-Lu, in a nice environment.
• Open-source openVA R package: https://cran.r-project.org/package=openVA
Table 1 summarizes the properties of these six algorithms and physician coding. In addition to
what SCI they use, the table identifies what outputs are produced and whether or not the method
is able to assess uncertainty in those outputs. There is a column labeled ‘Independent Symptoms’
that communicates whether or not the algorithm makes an assumption of independence among
symptoms given cause. This assumption makes the logic of all of the algorithms much simpler but
effectively ignores information contained in the co-occurrence or co-absence of symptoms. Finally,
the table lists what type of software is available for each algorithm.
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Table 1: VA Algorithms. SCI is ‘symptom-cause information’; PHMRC is ‘Population Health Metrics Research Consortium
gold standard VA dataset’ ; Outputs are ‘individual COD’, ‘CSMF’, or ‘both’; O-S is ‘open-source’; R is ‘R statistical programming
environment’.
Fundamental
Logic
Alternate SCI Indep.
Symptoms
Software
Algorithm SCI PHMRC InterVA Other Outputs Uncertainty Free O-S Platforms
InterVA ∼Bayes rule InterVA No Yes No Both No Yes Yes Yes All (R)
Tariff tariff scores PHMRC Yes No No Both No Yes Yes No Windows
SmartVA tariff scores PHMRC Yes No No Both No Yes Yes No Windows
InSilicoVA Bayes rule+ Various Yes Yes Yes Both Yes Yes Yes Yes All (R)
NBC Bayes rule Various Yes Yes Yes Both No Yes Yes Yes All (R)
King-Lu Bayes rule+ Various Yes No Yes CSMF No ∼No Yes Yes All (R)
Physicians Various
School &
Experience
No No Yes Both No No -NA- -NA- -NA-
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5 Recently Published Comparisons of the Performance of VA
Algorithms
There are three recent publications that present comprehensive comparisons of the performance of
commonly used algorithms.
Performance of four computer-coded verbal autopsy methods for cause of death as-
signment compared with physician coding on 24,000 deaths in low- and middle-income
countries (Desai et al., 2014).
Background: Physician-coded verbal autopsy (PCVA) is the most widely used method
to determine causes of death (CODs) in countries where medical certification of death is
uncommon. Computer-coded verbal autopsy (CCVA) methods have been proposed as
a faster and cheaper alternative to PCVA, though they have not been widely compared
to PCVA or to each other.
Methods: We compared the performance of open-source random forest, open-source
tariff method, InterVA-4, and the King-Lu method to PCVA on five datasets comprising
over 24,000 verbal autopsies from low- and middle-income countries. Metrics to assess
performance were positive predictive value and partial chance-corrected concordance at
the individual level, and cause-specific mortality fraction accuracy and cause-specific
mortality fraction error at the population level.
Results: The positive predictive value for the most probable COD predicted by the
four CCVA methods averaged about 43% to 44% across the datasets. The average
positive predictive value improved for the top three most probable CODs, with greater
improvements for open-source random forest (69%) and open-source tariff method (68%)
than for InterVA-4 (62%). The average partial chance-corrected concordance for the
most probable COD predicted by the open-source random forest, open-source tariff
method and InterVA-4 were 41%, 40% and 41%, respectively, with better results for the
top three most probable CODs. Performance generally improved with larger datasets.
At the population level, the King-Lu method had the highest average cause-specific
mortality fraction accuracy across all five datasets (91%), followed by InterVA-4 (72%
across three datasets), open-source random forest (71%) and open-source tariff method
(54%).
Conclusions: On an individual level, no single method was able to replicate the physi-
cian assignment of COD more than about half the time. At the population level, the
King-Lu method was the best method to estimate cause-specific mortality fractions,
though it does not assign individual CODs. Future testing should focus on combining
different computer-coded verbal autopsy tools, paired with PCVA strengths. This in-
cludes using open-source tools applied to larger and varied datasets (especially those
including a random sample of deaths drawn from the population), so as to establish the
performance for age- and sex-specific CODs.
Abstract verbatim from Desai et al. (2014)
Using verbal autopsy to measure causes of death: the comparative performance of
existing methods’ (Murray et al., 2014):
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Background: Monitoring progress with disease and injury reduction in many popula-
tions will require widespread use of verbal autopsy (VA). Multiple methods have been
developed for assigning cause of death from a VA but their application is restricted by
uncertainty about their reliability.
Methods: We investigated the validity of five automated VA methods for assigning
cause of death: InterVA-4, Random Forest (RF), Simplified Symptom Pattern (SSP),
Tariff method (Tariff), and King-Lu (KL), in addition to physician review of VA forms
(PCVA), based on 12,535 cases from diverse populations for which the true cause of
death had been reliably established. For adults, children, neonates and stillbirths, per-
formance was assessed separately for individuals using sensitivity, specificity, Kappa,
and chance-corrected concordance (CCC) and for populations using cause specific mor-
tality fraction (CSMF) accuracy, with and without additional diagnostic information
from prior contact with health services. A total of 500 train-test splits were used to
ensure that results are robust to variation in the underlying cause of death distribution.
Results: Three automated diagnostic methods, Tariff, SSP, and RF, but not InterVA-
4, performed better than physician review in all age groups, study sites, and for the
majority of causes of death studied. For adults, CSMF accuracy ranged from 0.764 to
0.770, compared with 0.680 for PCVA and 0.625 for InterVA; CCC varied from 49.2%
to 54.1%, compared with 42.2% for PCVA, and 23.8% for InterVA. For children, CSMF
accuracy was 0.783 for Tariff, 0.678 for PCVA, and 0.520 for InterVA; CCC was 52.5%
for Tariff, 44.5% for PCVA, and 30.3% for InterVA. For neonates, CSMF accuracy was
0.817 for Tariff, 0.719 for PCVA, and 0.629 for InterVA; CCC varied from 47.3% to
50.3% for the three automated methods, 29.3% for PCVA, and 19.4% for InterVA. The
method with the highest sensitivity for a specific cause varied by cause.
Conclusions: Physician review of verbal autopsy questionnaires is less accurate than
automated methods in determining both individual and population causes of death.
Overall, Tariff performs as well or better than other methods and should be widely
applied in routine mortality surveillance systems with poor cause of death certification
practices.
Abstract verbatim from Murray et al. (2014)
Probabilistic Cause-of-Death Assignment Using Verbal Autopsies (McCormick et al.,
2016a,b):
In regions without complete-coverage civil registration and vital statistics systems there
is uncertainty about even the most basic demographic indicators. In such regions, the
majority of deaths occur outside hospitals and are not recorded. Worldwide, fewer than
one-third of deaths are assigned a cause, with the least information available from the
most impoverished nations. In populations like this, verbal autopsy (VA) is a commonly
used tool to assess cause of death and estimate cause-specific mortality rates and the
distribution of deaths by cause. VA uses an interview with caregivers of the decedent
to elicit data describing the signs and symptoms leading up to the death. This article
develops a new statistical tool known as InSilicoVA to classify cause of death using
information acquired through VA. InSilicoVA shares uncertainty between cause of death
assignments for specific individuals and the distribution of deaths by cause across the
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population. Using side-by-side comparisons with both observed and simulated data, we
demonstrate that InSilicoVA has distinct advantages compared to currently available
methods. Supplementary materials for this article are available online.
Abstract verbatim from McCormick et al. (2016a)
The InSilicoVA publication presents a number of results:
• Development of the InSilicoVA algorithm.
• A simulation study of the performance of InSilicoVA.
• A method to de-bias physician-coded VAs.
• An application of InSilicoVA to community deaths with a comparison to InterVA.
• An application of InSilicoVA that includes both standard SCI and physician-coded deaths
that dramatically improves the performance of InSilicoVA.
• An SCI-controlled comparison of the performance of algorithms including InSilicoVA, In-
terVA, Tariff, and King-Lu.
The overall conclusion is that InSilicoVA performs well and generally better than the other al-
gorithms under a variety of tests (simulation, cross validation using gold standard deaths, and
application to community deaths with and without additional physician-coded deaths as auxiliary
SCI) and can be extended easily to use a variety of SCI and additional techniques to improve
performance.
In the SCI-controlled comparison, InSilicoVA consistently outperformed the other algorithms, but
all algorithms performed much less well when tested on deaths from PHMRC sites that were
not included to create their SCI. This clearly demonstrates the need for much better SCI that is
representative of community deaths in a wide variety of places and is updated through time, and
the fact that the PHMRC gold standard dataset is not sufficient as a general purpose, generalizable
source of SCI.
InSilicoVA is the only algorithm that quantifies uncertainty and the InSilicoVA publication is the
only publication describing an algorithm for which full replication code exists (by request from the
authors).
Table 2 presents a very brief summary of the comparisons conducted and conclusions reached by
each set of authors.
A number of other publications address the functioning and performance of VA algorithms and
related issues: e.g. Aleksandrowicz et al. (2014); Bauni et al. (2011); Byass et al. (2012); Byass
(2014); Flaxman et al. (2011, 2015); Fottrell et al. (2007); Fottrell and Byass (2010); Fottrell et al.
(2011); Garenne (2014); Oti and Kyobutungi (2010); Fantahun et al. (2006); Fottrell et al. (2011);
James et al. (2011); Jha (2014); King et al. (2008, 2010); Leitao et al. (2014); Lozano et al.
(2011); Miasnikof et al. (2015); Mohapatra (2016); Murray et al. (2011); Serina et al. (2015b,a);
World Health Organization (2012, 2017)
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Table 2: Recent Published Comparisons of VA Algorithm Performance. Def. is ‘Default SCI’; Cntr. is ‘Controlled (i.e.
identical) SCI’. Code communicates whether or note replication code is available for the publication. Only algorithms listed in the
text are summarized in this table.
SCI
Reference Compared Def. Cntr. Death Type Code Conclusion & Comments
Desai et al.
(2014)
Physician codes
compared to Tariff,
InterVA4, and King-Lu
Yes No Community No
Algorithm-assigned causes compared to
physician-assigned causes. All algorithms using
default SCI. Algorithms performed poorly at
replicating physician-assigned causes. Tariff
performed slightly better than InterVA4.
Murray et al.
(2014)
Algorithms to each
other: InterVA4, Tariff,
and King-Lu
Yes No Hospital No
Algorithm and physician-assigned causes
compared. All algorithms used default SCI and
comparisons down within PHMRC gold
standard data set. Tariff performed better than
physicians; InterVA4 performed worse than
physicians.
McCormick et al.
(2016a,b)
Algorithms to each
other: InSilicoVA,
InterVA4, Tariff,
King-Lu
Yes Yes Both Yes
Algorithm-assigned causes compared. All
algorithms used SCI derived from the PHMRC
gold standard dataset. All algorithms trained
using data from all or single sites within the
PHMRC data. All algorithms performed much
less well when trained and tested on deaths
from different sites within the PHMRC data.
In general InSilicoVA performed better than all
other algorithms, and InterVA4 performed
better than Tariff.
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6 Brief Conclusion
6.1 Performance of Algorithms
The published evidence comparing the performance of VA algorithms does not present a consensus
opinion that clearly identifies the ‘best’ algorithm. However, several clear conclusions can be
drawn:
• With regard to underlying logic, the consensus is that some form of Bayes rule is the most
fruitful approach, and with the sole exception of the Tariff family of methods, all algorithms
use Bayes rule.
• Except for McCormick et al. (2016a), all published comparisons conflate the effects of algo-
rithm logic and SCI, and that makes their results difficult to interpret.
• The McCormick et al. (2016a) publication makes it clear that the effects of SCI can far
outweigh differences in logic (see the SCI-controlled comparison done using PHMRC gold
standard data in the Supplementary Materials for the publication). Following directly from
this, it is clear that a concerted effort must be made to significantly and rapidly improve the
SCI available for VA algorithm developers and VA users.
• A standard set of VA deaths and SCI need to be developed to support future comparisons of
the performance of VA methods. This will ensure that variation in the test deaths and SCI
do not affect the comparisons done by different VA algorithm research groups.
• A standard comparison approach needs to be developed and utilized in all VA algorithm
comparisons.
• A standard set of VA algorithm performance metrics needs to be determined and reported in
all comparisons of VA algorithms.
6.2 SCI Archive – an Approach to Improved SCI
Because SCI relates VA symptoms to causes, the easiest and most reliable way to obtain SCI is
from deaths with VA and a cause(s) assigned through an independent mechanism. These ‘labeled’
deaths can be processed to produce a quantitative description of how each symptom or group of
symptoms is related to each cause. This typically consists of conditional probabilities of observing
a symptom or group of symptoms with a specific cause Pr(s|c) or Pr(s1, . . . , sn|c). The independent
mechanism for assigning causes to SCI deaths can be 1) a form of traditional medical certification,
including medical record review and/or medical autopsy, 2) traditional physician-assigned causes
using the VA data, or 3) a variety of mixtures of the two with perhaps additional information from
clinical records and/or minimally-invasive tissue samples.
To allow automated cause assignment methods to be used with confidence in routine mortality
surveillance in multiple settings and as time progresses, it is necessary to have SCI based on deaths
from a wide variety of settings that accumulate continuously. This variety can be achieved by
continuously pooling deaths with VA and an independently-assigned cause(s) from various settings
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and updating SCI based on those deaths on a regular schedule. Then by definition the resulting
SCI are both widely representative and continuously updated.
The practical implementation of such an idea is a centralized archive of deaths with VA and an
independently-assigned cause(s) that continuously accepts deaths from a widely dispersed group
of collaborators and periodically updates and disseminates SCI based on those deaths – the SCI
Archive. This is a straightforward idea, but actually implementing it will require working through
some practical details.
• Ethical/legal concerns: privacy, data ownership, etc.
• Data definitions for the VA symptoms and cause lists.
• Quality assurance metrics for both the VAs and alternative cause assignment mechanisms.
• Accessibility and dissemination formats, frequencies, etc.
• Metadata definitions.
• De-biasing data requirements for traditional physician-assigned causes (and perhaps others),
see (McCormick et al., 2016a).
• Computing/data management design and maintenance plans.
• Physical computing infrastructure requirements.
• Human resource needs, setup and maintenance phases.
A common desire among VA users in routine surveillance settings is to have automated cause-
assignment algorithms ‘replicate what our physicians would do’ with VA data. This replication
can be achieved by using SCI based on deaths with physician-coded VAs representative of the
area of VA implementation. Physicians code VA deaths with their own idiosyncratic bias, and
that is one of the primary motivations for developing algorithms. This bias can be quantified and
eliminated in the preparation of SCI from physician-coded VAs provided two conditions are met
(McCormick et al., 2016a):
1. each VA death is read and coded by at least two physicians and
2. each physician reads and codes many VAs.
Physician-coded VAs that meet these conditions are ‘de-biased physician coded VAs’ or
DBPCVA.
A potential way to quickly get the the SCI Archive up and running would be to start with DBPCVA
deaths contributed by any VA user willing to provide them. The resulting SCI would enable
automated cause-assignment algorithms to assign causes in a way that replicates what non-biased
physicians would do. The WHO Working Group on VA is exploring the idea of setting up an SCI
archive of this type at the WHO.
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